International Journal for Quality in Health Care 15:413-421 (2003)
© 2003 International Society for Quality in Health Care
Readmissions and the quality of care in patients hospitalized with heart failure
1 Institute of Social and Preventive Medicine, University of Lausanne, Switzerland,2 Epidemiology Department, Rollins School of Public Health, Emory University, Atlanta, GA,3 Kerr L. White Institute for Health Services Research, Decatur, GA,4 Catalan Agency for Health Technology Assessment, Barcelona, Spain,5 Baylor Health Care System, Dallas, TX, and6 Georgia Medical Care Foundation, Atlanta, GA, USA
Objectives. Clinical practice guidelines based on the results of randomized clinical trials recommend that patients with heart failure due to left ventricular systolic dysfunction (LVSD) be treated with angiotensin-converting enzyme inhibitors (ACEI) at doses shown to reduce mortality and readmission. This study examined the relationship between ACEI use at discharge and readmission among patients with heart failure due to LVSD.
Methods and results. Data were abstracted from the medical records of 2943 randomly selected patients hospitalized for heart failure in 50 hospitals. The outcome of interest was the number of readmissions occurring up to 21 months after discharge. Six-hundred and eleven patients were eligible for analysis. Compared with patients discharged at a recommended ACEI dose, patients not prescribed an ACEI at discharge had an adjusted rate ratio of readmission (RR) of 1.74 [95% confidence interval (CI) 1.22–2.48], while patients prescribed an ACEI at less than a recommended dose had an RR of 1.24 (95% CI 0.91–1.69) (P = 0.005 for the trend).
Conclusion. Our results show that ACEI use at discharge in patients with LVSD is associated with decreased rate of readmission. These findings suggest that compliance with the ACEI prescribing recommendations listed in clinical practice guidelines for patients with heart failure due to LVSD confers benefit.
Keywords: angiotensin-converting enzyme inhibitors, heart failure, left ventricular systolic dysfunction, outcome assessment, quality of health care, readmissions
Address reprint requests to Jean-Christophe Luthi, M.D., M.P.H., Health Care Evaluation Unit, Institute of Social and Preventive Medicine, University of Lausanne, Bugnon 17, CH-1005 Lausanne, Switzerland. E-mail: Jean-Christophe.Luthi{at}inst.hospvd.ch
Accepted for publication April 9, 2003.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Hallerbach, A. Francoeur, S. C. Pomerantz, C. Oliner, D. L. Morris, G. Eiger, J. Cohn, and M. Goldfinger Patterns and Predictors of Early Hospital Readmission in Patients With Congestive Heart Failure American Journal of Medical Quality, February 1, 2008; 23(1): 18 - 23. [Abstract] [PDF]
|
|
|
|
|
|
Lin Guo, E. S. Chung, D. E. Casey JR, and R. Snow Redefining Hospital Readmissions to Better Reflect Clinical Course of Care for Heart Failure Patients American Journal of Medical Quality, March 1, 2007; 22(2): 98 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 G. C. Fonarow, W. T. Abraham, N. M. Albert, W. G. Stough, M. Gheorghiade, B. H. Greenberg, C. M. O'Connor, K. Pieper, J. L. Sun, C. Yancy, et al. Association Between Performance Measures and Clinical Outcomes for Patients Hospitalized With Heart Failure JAMA, January 3, 2007; 297(1): 61 - 70. [Abstract] [Full Text] [PDF]
|
|